Anthony Boral Net Worth & Insider Trades
Anthony Boral - Chief Medical Officer, Blueprint Medicines Corp
What is Anthony Boral's Net Worth?
The current estimated net worth of Blueprint Medicines Corp's Chief Medical Officer, Anthony Boral, is estimated to be about $8.46M . Anthony Boral owns about 28,147 units of Blueprint Medicines Corp common stock. In the last 4 years at Blueprint Medicines Corp, Anthony Boral has sold an estimated value of $7.23M worth.
What is Anthony Boral's Past Insider Trading?
Anthony Boral's largest purchase order was 23,136 units , worth over $264.95K on September 21, 2020. Anthony Boral's largest sale order was 23,136 units , worth over $1.85M on September 21, 2020. In total, Anthony Boral has made about 16 transactions over 4 years of their time at Blueprint Medicines Corp. Anthony Boral usually trades in March and February, with the busiest year in 2020. The most recent transaction was a sale order of 10,000 units , worth over $1.19M on December 16, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anthony Boral
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Anthony Boral's' Mailing Address?
- Mailing address is Blueprint Medicines Corp. 215 First Street, Suite 340/350 Cambridge MA 02142 MA
Blueprint Medicines Corp Executive Compensation
Name |
Year
|
Salary
|
Total
|
|---|---|---|---|
| Jeffrey W. Albers | 2020 | $645,000 | $6,344,667 |
| Jeffrey W. Albers | 2019 | $590,000 | $9,362,371 |
| Jeffrey W. Albers | 2018 | $541,144 | $9,740,799 |
| Michael Landsittel | 2020 | $379,575 | $2,014,974 |
| Michael Landsittel | 2019 | $345,000 | $1,958,720 |
| Michael Landsittel | 2018 | $281,678 | $1,740,610 |
| Fouad Namouni, M.D. | 2020 | $186,154 | $6,668,732 |
| Fouad Namouni, M.D. | 2019 | - | - |
| Fouad Namouni, M.D. | 2018 | - | - |
| Kathryn Haviland | 2020 | $460,944 | $2,363,556 |
| Kathryn Haviland | 2019 | $431,830 | $3,090,423 |
| Kathryn Haviland | 2018 | $392,589 | $2,601,762 |
| Tracey L. McCain, Esq. | 2020 | $453,301 | $2,346,428 |
| Tracey L. McCain, Esq. | 2019 | $437,972 | $2,900,568 |
| Tracey L. McCain, Esq. | 2018 | $425,216 | $2,647,962 |
| No matching records found | |||
Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm
What are Blueprint Medicines Corp's Past Insider Trades?
Blueprint Medicines Corp's most recent insider trade came on August 28, 2023 by Jeffrey Albers who sold 25,000 units worth $1.25M . In the last 8 years, insiders at Blueprint Medicines Corp have sold an estimated value of $176.92M and bought an estimated value of $17.68M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers, Kate Haviland, CHIEF EXECUTIVE OFFICER, and Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER .
Blueprint Medicines Corp Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||